|
|
|
|
|
|
| Infiltrating Lobular Carcinoma |
| Etiology Unknown |
| Pathogenesis Unknown ? BRCA1 mutations, |
| Epidemiology Between 3-14% of invasive carcinomas of the breast depending on microscopic criteria for diagnosis More common in older women with breast cancer |
| General Gross Description Mass may be firm to hard or not readily palpable or visible May be detected mammographically, although microcalcifications are uncommon |
| General Microscopic Description Neoplastic cells infiltrate in small linear groups: "Indian file" Circle around preexisting benign ducts forming a "target" Some variants are recognized with solid, tubulolobular or alveolar patterns Intracytoplasmic lumens may be identified by electron microscopy Mucin vacuoles creating a signet ring appearance with a nucleus pressed against the cytoplasmic membrane by a large mucin vacuole may be seen. |
| Clinical Correlation Bilaterality ranges from 6-28% Neoplasms spread to axillary lymph nodes and then disseminate to lungs, liver, and bone Therapy dependent on stage with treatment similar to that with invasive duct carcinoma |
| References Rosen PP, Oberman H. Tumors of the Mammary Gland. Washington, AFIP, 1993, pp. 168-175. |
| Infiltrating Lobular Carcinoma |
| Synopsis by: Melinda Sanders M.D. (T04000M85203)[315] |
| Search Medline at National Library of Medicine Please be patient during transfer. Medline will open in a new window. To return, close the Medline Window |
|
|
|
|
|
|